Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2096671 Target Snapshot

Serotonin 2 (5-HT2) receptor · PROTEIN FAMILY · Mus musculus

168Compounds
11Assays
3Approved Drugs
182.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q02152. Use UniProt Q02152 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q02152 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Serotonin 2 (5-HT2) receptor as ChEMBL target CHEMBL2096671, mapped to UniProt Q02152. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Serotonin 2 (5-HT2) receptor
PROTEIN FAMILY · Mus musculus
As of 2026-09-14
ChEMBL target ID
CHEMBL2096671
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q02152
5-hydroxytryptamine receptor 2B
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Serotonin 2 (5-HT2) receptor is the right protein anchor across sources, using UniProt Q02152 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein Label5-hydroxytryptamine receptor 2B
UniProt AccessionQ02152
Component TypeProtein
Sequence Length479 aa

5-hydroxytryptamine receptor 2B

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Serotonin 2 (5-HT2) receptor, mapped to UniProt Q02152. ChEMBL maps the protein component as 5-hydroxytryptamine receptor 2B. Sequence length is 479 aa.

Mapped IDQ02152
Review nameSerotonin 2 (5-HT2) receptor
OrganismMus musculus
Clinical Profile

Clinical Phase Distribution

3
Approved
2
Phase III
2
Phase II
Assay Mix

Activity Type Distribution

IC5030.0
KI152.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL141319 9.54 IC50 0.29 Preclinical
CHEMBL343838 9.46 IC50 0.35 Preclinical
CHEMBL267777 9.09 Ki 0.82 Clinical
CHEMBL36645 9.09 Ki 0.82 Preclinical
CHEMBL142850 9.07 IC50 0.85 Preclinical
CHEMBL38078 9.07 Ki 0.85 Preclinical
CHEMBL343228 8.92 IC50 1.2 Preclinical
CHEMBL141438 8.89 IC50 1.3 Preclinical
CHEMBL142456 8.89 IC50 1.3 Preclinical
CHEMBL141392 8.82 IC50 1.5 Preclinical
Distribution

pChEMBL Value Distribution

7
5.0
12
5.5
21
6.0
32
6.5
14
7.0
21
7.5
12
8.0
19
8.5
5
9.0
1
9.5
pChEMBL
Approved Drugs

Approved Drugs

RISPERIDONE
CHEMBL85
Approved 1993
CLOZAPINE
CHEMBL42
Approved 1989
HALOPERIDOL
CHEMBL54
Approved 1967
Assay Landscape

Assay Landscape

11
Total Assays
144
Tested Compounds
1
Assay Types
Binding — 11 assays, 144 compounds
BAO Format Assays Compounds Avg pChEMBL
protein format 4 102 7.2
tissue-based format 4 6 4.9
organism-based format 2 0
assay format 1 36 7.4

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine